Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Udayana University, Bali, Indonesia.
J ASEAN Fed Endocr Soc. 2022;37(1):69-74. doi: 10.15605/jafes.037.01.13. Epub 2022 Apr 21.
is a promising gut microbiota for the treatment of type 2 diabetes mellitus (T2DM). stimulates intestinal wall integrity, is an anti-inflammatory agent, and reduces endoplasmic reticulum stress, lipogenesis and gluconeogenesis. These properties make a potential treatment option for T2DM by reducing insulin resistance and increasing insulin sensitivity and glucose tolerance in different tissues. This article explores the possible role of in T2DM management, along with the various methods known to modulate .
是一种很有前途的肠道微生物群,可用于治疗 2 型糖尿病(T2DM)。 可刺激肠壁完整性,具有抗炎作用,并可减轻内质网应激、脂肪生成和糖异生。这些特性使 成为 T2DM 的一种潜在治疗选择,可降低胰岛素抵抗,提高不同组织的胰岛素敏感性和葡萄糖耐量。本文探讨了 在 T2DM 管理中的可能作用,以及已知可调节 的各种方法。